Kathy Szeliga

Sponsored bills

• HB1093: Health Insurance - Provider Panels - Requirements
• HB1091: Health Insurance and Dental Plan Organizations - Dentists - Assignment of Benefits and Reimbursement of Nonpreferred Providers
• HB1523: Alcohol, Tobacco, and Cannabis Commission - Unauthorized Consumable Products - Enforcement and Seizure
• HB1559: Children in Unlicensed Settings and Pediatric Hospital Overstay Patients - Placement
• HB1483: Clinical Professional Counseling - Out-of-State Providers - Use of Telehealth for Continuity of Care
• HB1377: Prescription Drug Repository Program - Redirecting Safe Prescription Drugs Pilot Program
• HB1376: Maryland Medical Assistance Program, Maryland Children's Health Program, and Health Insurance - Transfers to Special Pediatric Hospitals - Requirements
• HB1181: Family Law - Children in Out-of-Home Placement - Voluntary Placement Agreements
• HB1015: Developmental Disabilities Services - Expedited Eligibility Determinations for Recently Relocated Individuals (Ralph's Act)
• HB939: Certificates of Birth - Filing - Time Period
• HB374: State Acupuncture Board - Revisions
• HB1094: Health Insurance - Graduate-Level Clinical Interns - Required Reimbursement
• HB1002: Nursing Facilities - Involuntary Discharge or Transfer
• HB947: Natural Resources - Invasive Blue Catfish Pilot Program - Alterations
• HB838: State Board of Pharmacy - Prescriber-Pharmacist Agreements
• HB747: Oversight Committee on Quality of Care in Nursing Homes and Assisted Living Facilities – Membership
• HB322: Maryland Health Care Commission - Membership
• HB1117: Virginia I. Jones Alzheimer's Disease and Related Dementias Council and the Advisory Stakeholder Group on Autism-Related Needs - Recommendations for Elopement Response Devices
• HB417: Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
• HB1014: Mental Health Law - Danger to the Life or Safety of the Individual or of Others - Definition (Right to Treatment)